Highlights

[PHARMA] QoQ TTM Result on 2012-06-30 [#2]

Stock [PHARMA]: PHARMANIAGA BHD
Announcement Date 08-Aug-2012
Admission Sponsor -
Sponsor -
Financial Year 31-Dec-2012
Quarter 30-Jun-2012  [#2]
Profit Trend QoQ -     2.74%    YoY -     87.92%
Quarter Report


View:


Show?  QoQ % Horiz. %

TTM Result
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
Revenue 1,865,940 1,812,346 1,697,728 1,642,700 1,582,398 1,520,981 1,529,311 14.17%
  QoQ % 2.96% 6.75% 3.35% 3.81% 4.04% -0.54% -
  Horiz. % 122.01% 118.51% 111.01% 107.41% 103.47% 99.46% 100.00%
PBT 97,283 103,314 115,434 102,587 94,349 73,186 54,117 47.79%
  QoQ % -5.84% -10.50% 12.52% 8.73% 28.92% 35.24% -
  Horiz. % 179.76% 190.91% 213.30% 189.57% 174.34% 135.24% 100.00%
Tax -37,985 -40,108 -32,578 -34,308 -28,102 -20,401 -15,466 81.94%
  QoQ % 5.29% -23.11% 5.04% -22.08% -37.75% -31.91% -
  Horiz. % 245.60% 259.33% 210.64% 221.83% 181.70% 131.91% 100.00%
NP 59,298 63,206 82,856 68,279 66,247 52,785 38,651 32.99%
  QoQ % -6.18% -23.72% 21.35% 3.07% 25.50% 36.57% -
  Horiz. % 153.42% 163.53% 214.37% 176.66% 171.40% 136.57% 100.00%
NP to SH 57,797 61,711 81,587 67,151 65,358 52,157 37,959 32.32%
  QoQ % -6.34% -24.36% 21.50% 2.74% 25.31% 37.40% -
  Horiz. % 152.26% 162.57% 214.93% 176.90% 172.18% 137.40% 100.00%
Tax Rate 39.05 % 38.82 % 28.22 % 33.44 % 29.79 % 27.88 % 28.58 % 23.11%
  QoQ % 0.59% 37.56% -15.61% 12.25% 6.85% -2.45% -
  Horiz. % 136.63% 135.83% 98.74% 117.00% 104.23% 97.55% 100.00%
Total Cost 1,806,642 1,749,140 1,614,872 1,574,421 1,516,151 1,468,196 1,490,660 13.66%
  QoQ % 3.29% 8.31% 2.57% 3.84% 3.27% -1.51% -
  Horiz. % 121.20% 117.34% 108.33% 105.62% 101.71% 98.49% 100.00%
Net Worth 484,829 472,037 496,469 481,394 474,161 514,153 464,092 2.95%
  QoQ % 2.71% -4.92% 3.13% 1.53% -7.78% 10.79% -
  Horiz. % 104.47% 101.71% 106.98% 103.73% 102.17% 110.79% 100.00%
Dividend
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
Div 41,189 41,188 64,713 52,948 44,120 35,296 0 -
  QoQ % 0.00% -36.35% 22.22% 20.01% 25.00% 0.00% -
  Horiz. % 116.70% 116.69% 183.34% 150.01% 125.00% 100.00% -
Div Payout % 71.27 % 66.74 % 79.32 % 78.85 % 67.51 % 67.67 % - % -
  QoQ % 6.79% -15.86% 0.60% 16.80% -0.24% 0.00% -
  Horiz. % 105.32% 98.63% 117.22% 116.52% 99.76% 100.00% -
Equity
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
Net Worth 484,829 472,037 496,469 481,394 474,161 514,153 464,092 2.95%
  QoQ % 2.71% -4.92% 3.13% 1.53% -7.78% 10.79% -
  Horiz. % 104.47% 101.71% 106.98% 103.73% 102.17% 110.79% 100.00%
NOSH 117,676 117,715 117,646 117,700 117,657 117,655 106,933 6.58%
  QoQ % -0.03% 0.06% -0.05% 0.04% 0.00% 10.03% -
  Horiz. % 110.05% 110.08% 110.02% 110.07% 110.03% 110.03% 100.00%
Ratio Analysis
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
NP Margin 3.18 % 3.49 % 4.88 % 4.16 % 4.19 % 3.47 % 2.53 % 16.45%
  QoQ % -8.88% -28.48% 17.31% -0.72% 20.75% 37.15% -
  Horiz. % 125.69% 137.94% 192.89% 164.43% 165.61% 137.15% 100.00%
ROE 11.92 % 13.07 % 16.43 % 13.95 % 13.78 % 10.14 % 8.18 % 28.50%
  QoQ % -8.80% -20.45% 17.78% 1.23% 35.90% 23.96% -
  Horiz. % 145.72% 159.78% 200.86% 170.54% 168.46% 123.96% 100.00%
Per Share
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
RPS 1,585.65 1,539.60 1,443.07 1,395.66 1,344.91 1,292.74 1,430.15 7.12%
  QoQ % 2.99% 6.69% 3.40% 3.77% 4.04% -9.61% -
  Horiz. % 110.87% 107.65% 100.90% 97.59% 94.04% 90.39% 100.00%
EPS 49.11 52.42 69.35 57.05 55.55 44.33 35.50 24.13%
  QoQ % -6.31% -24.41% 21.56% 2.70% 25.31% 24.87% -
  Horiz. % 138.34% 147.66% 195.35% 160.70% 156.48% 124.87% 100.00%
DPS 35.00 35.00 55.00 44.99 37.50 30.00 0.00 -
  QoQ % 0.00% -36.36% 22.25% 19.97% 25.00% 0.00% -
  Horiz. % 116.67% 116.67% 183.33% 149.97% 125.00% 100.00% -
NAPS 4.1200 4.0100 4.2200 4.0900 4.0300 4.3700 4.3400 -3.41%
  QoQ % 2.74% -4.98% 3.18% 1.49% -7.78% 0.69% -
  Horiz. % 94.93% 92.40% 97.24% 94.24% 92.86% 100.69% 100.00%
Adjusted Per Share Value based on latest NOSH - 1,309,126
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
RPS 142.53 138.44 129.68 125.48 120.87 116.18 116.82 14.17%
  QoQ % 2.95% 6.76% 3.35% 3.81% 4.04% -0.55% -
  Horiz. % 122.01% 118.51% 111.01% 107.41% 103.47% 99.45% 100.00%
EPS 4.41 4.71 6.23 5.13 4.99 3.98 2.90 32.21%
  QoQ % -6.37% -24.40% 21.44% 2.81% 25.38% 37.24% -
  Horiz. % 152.07% 162.41% 214.83% 176.90% 172.07% 137.24% 100.00%
DPS 3.15 3.15 4.94 4.04 3.37 2.70 0.00 -
  QoQ % 0.00% -36.23% 22.28% 19.88% 24.81% 0.00% -
  Horiz. % 116.67% 116.67% 182.96% 149.63% 124.81% 100.00% -
NAPS 0.3703 0.3606 0.3792 0.3677 0.3622 0.3927 0.3545 2.95%
  QoQ % 2.69% -4.91% 3.13% 1.52% -7.77% 10.78% -
  Horiz. % 104.46% 101.72% 106.97% 103.72% 102.17% 110.78% 100.00%
Price Multiplier on Financial Quarter End Date
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
Date 29/03/13 31/12/12 28/09/12 29/06/12 30/03/12 30/12/11 30/09/11 -
Price 8.2600 8.1000 7.5500 10.1800 5.9000 5.3600 5.9000 -
P/RPS 0.52 0.53 0.52 0.73 0.44 0.41 0.41 17.15%
  QoQ % -1.89% 1.92% -28.77% 65.91% 7.32% 0.00% -
  Horiz. % 126.83% 129.27% 126.83% 178.05% 107.32% 100.00% 100.00%
P/EPS 16.82 15.45 10.89 17.84 10.62 12.09 16.62 0.80%
  QoQ % 8.87% 41.87% -38.96% 67.98% -12.16% -27.26% -
  Horiz. % 101.20% 92.96% 65.52% 107.34% 63.90% 72.74% 100.00%
EY 5.95 6.47 9.19 5.60 9.42 8.27 6.02 -0.78%
  QoQ % -8.04% -29.60% 64.11% -40.55% 13.91% 37.38% -
  Horiz. % 98.84% 107.48% 152.66% 93.02% 156.48% 137.38% 100.00%
DY 4.24 4.32 7.28 4.42 6.36 5.60 0.00 -
  QoQ % -1.85% -40.66% 64.71% -30.50% 13.57% 0.00% -
  Horiz. % 75.71% 77.14% 130.00% 78.93% 113.57% 100.00% -
P/NAPS 2.00 2.02 1.79 2.49 1.46 1.23 1.36 29.29%
  QoQ % -0.99% 12.85% -28.11% 70.55% 18.70% -9.56% -
  Horiz. % 147.06% 148.53% 131.62% 183.09% 107.35% 90.44% 100.00%
Price Multiplier on Announcement Date
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
Date 15/05/13 18/02/13 06/11/12 08/08/12 03/05/12 22/02/12 01/11/11 -
Price 9.2600 7.8000 8.2500 8.8300 5.9000 5.9000 5.9000 -
P/RPS 0.58 0.51 0.57 0.63 0.44 0.46 0.41 25.99%
  QoQ % 13.73% -10.53% -9.52% 43.18% -4.35% 12.20% -
  Horiz. % 141.46% 124.39% 139.02% 153.66% 107.32% 112.20% 100.00%
P/EPS 18.85 14.88 11.90 15.48 10.62 13.31 16.62 8.75%
  QoQ % 26.68% 25.04% -23.13% 45.76% -20.21% -19.92% -
  Horiz. % 113.42% 89.53% 71.60% 93.14% 63.90% 80.08% 100.00%
EY 5.30 6.72 8.41 6.46 9.42 7.51 6.02 -8.13%
  QoQ % -21.13% -20.10% 30.19% -31.42% 25.43% 24.75% -
  Horiz. % 88.04% 111.63% 139.70% 107.31% 156.48% 124.75% 100.00%
DY 3.78 4.49 6.67 5.09 6.36 5.08 0.00 -
  QoQ % -15.81% -32.68% 31.04% -19.97% 25.20% 0.00% -
  Horiz. % 74.41% 88.39% 131.30% 100.20% 125.20% 100.00% -
P/NAPS 2.25 1.95 1.95 2.16 1.46 1.35 1.36 39.84%
  QoQ % 15.38% 0.00% -9.72% 47.95% 8.15% -0.74% -
  Horiz. % 165.44% 143.38% 143.38% 158.82% 107.35% 99.26% 100.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.



  Be the first to like this.
 


FEATURED POSTS

1. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!

TOP ARTICLES

1. Health minister: Traveller from South Africa on Nov 19 is Malaysia’s first Omicron case save malaysia!
2. WHO urges Asia-Pacific to ready for Omicron-driven surge in infections Good Articles to Share
3. The case of ATA IMS: A tip of the iceberg? By Veeriah save malaysia!
4. Aurelius Technologies Bhd - Global EMS Provider PublicInvest Research
5. 3QCY21 Results Review - Fat Tails Kenanga Research & Investment
6. Strategy - A decent 3Q2021 but uncertainty has increased AmInvest Research Reports
7. Latest Land Disposal in Sg Tiram, Johor, shows Palm Oil Companies with Huge Landbanks with Cheap Book Value are Jewels, Calvin Tan THE INVESTMENT APPROACH OF CALVIN TAN
8. UWC: The Earnings far too little & dividend too small to justify such lofty high prices (IT WILL CRASH) BETTER RUN! Calvin Tan THE INVESTMENT APPROACH OF CALVIN TAN
APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
View candlestick stock charts with Technical indicators
MQ Affiliate
Be rewarded by being an MQ Affiliate
 
 

362  474  546  892 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 VSOLAR 0.015-0.005 
 VS 1.15-0.27 
 THHEAVY 0.015-0.05 
 VS-WB 0.355-0.09 
 IMPIANA 0.085+0.005 
 INARI 3.87-0.23 
 GOCEAN 0.0350.00 
 DNEX 0.745-0.025 
 ATAIMS 0.445+0.035 
 EAH 0.02+0.005 
PARTNERS & BROKERS